Home  >  Article  >  Technology peripherals  >  "Dancer on the Egg Membrane": Domestic surgical robots have been approved for launch. Who will challenge the leading position of "Da Vinci"?

"Dancer on the Egg Membrane": Domestic surgical robots have been approved for launch. Who will challenge the leading position of "Da Vinci"?

王林
王林forward
2023-05-28 13:20:261093browse

"Dancer on the Egg Membrane": The launch of domestic surgical robots has been approved and accelerated. Who will challenge the leading position of "Da Vinci"?

Dancer on the Egg Membrane: Domestic surgical robots have been approved for launch. Who will challenge the leading position of Da Vinci?

China Times (www.chinatimes.net.cn) reporters Guo Yilin Yu Na reporting from Shanghai

"Small incisions and refinement" are the intuitive changes brought by surgical robots to surgical plans.

The 87th China International Medical Equipment Fair (CMEF) was held in Shanghai from May 14th to 17th. At this year's conference, companies such as Minimally Invasive Medical, Shurui Robot, Jingfeng Medical, and Yida Health presented their latest products, demonstrating laparoscopic surgical robots that comprehensively cover important and complex clinical procedures in the thoracic, abdominal, and pelvic areas.

The Shurui single-hole surgical robot is demonstrating its ability to shell quail eggs at the Shurui Robot booth. As the minimally invasive medical company with the most widely segmented product pipeline in China, its booth is divided into independent departments such as surgery and orthopedics, displaying its entire line of products. The Meda Health booth focuses on displaying the IQQA-Guide intelligent surgical navigation robot. In addition, Jingfeng Medical brought 5 cutting-edge technology products.

Looking at various innovation achievements, precision, digitization, and personalization are the clinical advantages of these medical devices, and surgical robots are representative products of this medical innovation trend. In this regard, the on-site person in charge of Shurui Robot told a reporter from China Times, “Robot-assisted surgery can relieve doctors’ fatigue during surgery. Single-hole surgical robots represent the future development direction of minimally invasive surgery and can truly benefit everyone. Doctors and patients. The person in charge of Jingfeng Medical told this reporter that surgical robots have brought innovative impetus to the industry. In the future, the new profit growth point in the field of surgical robots will be precision, digitalization and intelligent means. In technology Above all, the key point is whether the clinical effect of the product can solve the pain points of traditional surgery and achieve the stability, accuracy and convenience of the operation."

Surgical robot launches fine challenge

The "Da Vinci Surgical Robot" of the United States is a pearl in the robot industry and is regarded as the leader in the world's surgical robot industry. In China, as the national level has incorporated robots and intelligent manufacturing into priority areas of national scientific and technological innovation, a number of outstanding companies have emerged in the Chinese surgical robot market.

The reporter first arrived at the minimally invasive medical booth on the morning of May 14. The blue and white design of the booth highlighted its sense of technology. Following the introduction of the commentator, the reporter learned that the company currently has three commercial products, namely the three-dimensional electronic laparoscopic dragonfly eye, the four-arm laparoscopic surgical robot Tumai, and the orthopedic surgical robot Honghu, which will be launched in June 2021 and 2022 respectively. In January 2020 and April 2022, it obtained the marketing registration certificate issued by the National Medical Products Administration (NMPA). Tumai is the first domestic four-arm laparoscopic surgical robot approved for use in urological surgery. Honghu is approved for total knee replacement.

The on-site commentator told reporters, "The Tumai® endoscopic robot, which was built by MicroPort® Robot Group in eight years, is the first four-arm endoscopic surgical robot developed by a Chinese company and approved for sale. As of now, MicroPort® Chuang® Tumai® continues to challenge difficult surgical procedures in urology, thoracic surgery, hepatobiliary and pancreatic surgery, gynecology, gastrointestinal surgery and other departments, assisting clinical experts to achieve breakthroughs in many domestic surgical robots."

The Shurui single-hole surgical robot is demonstrating its quail egg shelling skills in the Shurui Robot exhibition area. The engineer operated the surgical instruments on the main console. Four surgical instruments entered the simulated abdominal cavity through a small incision of only 2.5 centimeters. After unfolding, they peeled off the thin quail egg shells one by one. With the cooperation of several surgical instruments, the quail egg membrane was not broken at all, which fully demonstrated the precise, safe and controllable operating performance of the Shurui robot.

Dancer on the Egg Membrane: Domestic surgical robots have been approved for launch. Who will challenge the leading position of Da Vinci?

Photography/Guo Yilin

On-site staff told reporters, “This demonstration has high requirements for the accuracy, safety and controllability of product operation, which is exactly what surgeons need when performing operations. According to reports, Shurui Robot It can be used in different departments such as urology, gynecology, pediatrics, general surgery, and thoracic surgery.

In addition, in the Jingfeng Medical exhibition area, the reporter once again saw the "robot dancer on the egg membrane". What is different from the previous one is that Jingfeng Medical chose to use videos to show the robot peeling quail eggs, sewing raw egg membranes, folding pocket paper cranes, etc. During the operation of peeling quail eggs, the thickness of the egg membrane is only 60 microns. Professionals control the Jingfeng surgical robot to extend 4 dexterous robotic arms, and perform ultra-fine and precise operations such as pinching and peeling by watching the 3D image of the surgical area. For highly difficult movements, the robotic arm simulates the human arm, restores the hand movements of a surgeon, filters out the tremors of the human hand itself, and completes the shelling operation without any damage.

Dancer on the Egg Membrane: Domestic surgical robots have been approved for launch. Who will challenge the leading position of Da Vinci?

Photography/Guo Yilin

The inevitable trend of future surgical development is to use surgical robots to replace traditional manual surgeries, the on-site explainer told reporters. Robotic surgical systems are capable of highly precise surgical operations, thereby reducing surgical errors and improving surgical success rates. The robotic surgical system performs surgery stably, eliminating the shaking of the doctor's hands, thus improving the safety of the surgery. In addition, the robotic surgical system provides a high-definition three-dimensional view, which is more conducive to precise cutting and suturing, and can also reduce fatigue during the operation. ”

Then the reporter went all the way to the Yida Health exhibition area. The reporter observed at the scene that the commentator was introducing the intelligent surgical navigation robot IQQA-Guide. It is reported that IQQA-Guide is based on a personalized 3D fully quantified electronic map of organs. The entire three-dimensional quantified image is positioned, tracked, guided and monitored in real time, which can assist doctors to improve surgical prognosis and thereby reduce surgical risks. This system can be combined with the intelligent cloud service platform to assist doctors in performing various minimally invasive interventional surgeries for thoracic and abdominal tumors.

"Before the operation, the surgeon used IQQA intelligent three-dimensional fully quantitative reconstruction technology to evaluate and analyze the patient's condition, accurately locate the lesion and its spatial relationship with surrounding blood vessels and bronchial segments, and formulate a precise surgical plan. During the operation, through IQQA- The Guide intelligent surgical navigation robot dynamically tracks and displays the path, distance, angle, etc. from the puncture needle tip to the lesion in real time throughout the entire process, monitors and positions the entire process, and assists doctors to effectively avoid important blood vessels and avoid risks such as postoperative infection and bleeding. Currently, this intelligent surgical navigation robot The robot has passed the national-level medical device innovation 'green channel' qualification and the NMPA certification of the State Food and Drug Administration, and is widely used in clinical practice."

Policies promote the development of surgical robots

Behind the rapid development of the surgical robot industry, it is inseparable from the promotion at the policy level. In recent years, the state has promulgated a series of regulations and policies to encourage the innovation of high-end medical imaging equipment and speed up the review and approval of medical devices, thus promoting my country's high-end medical equipment to accelerate into a new stage of domestic substitution.

On January 19, 2023, the "Notice on the Implementation Plan for the "Robot" Application Action" jointly issued by the Ministry of Industry and Information Technology and other 17 departments proposed to develop consulting services, surgeries, auxiliary examinations, auxiliary rounds, and critical care and first aid , life support, rehabilitation, inspection and sampling, disinfection and cleaning and other medical robot products.

In addition, for the import of surgical robots, the "Most Favored Nation Tax Rate Table for Certain Information Technology Products" shows that starting from January 2023, the zero tax rate for MFN imports will be implemented to encourage foreign surgical robot products and technologies to enter the Chinese market. This means that surgical robots, including Da Vinci, will have zero tariffs. It is reported that these companies have vigorously promoted the localization process of surgical robots in the past. With this reduction in tariffs, they are likely to lower the price of imported surgical robots, which will help promote surgery. The application of robots.

A surgical robot exhibitor told a reporter from China Times, “With the aging of the population, the incidence of various serious diseases has increased, which has put forward higher requirements for surgical technology. The characteristics of surgical robots can meet the current needs. China's market demand will help alleviate or even solve the imbalance between supply and demand of medical services and comprehensively improve the efficiency of medical supply."

The reporter learned at the exhibition site that many exhibitors had similar views. They believe that "domestic surgical robots stand on the shoulders of 'giants', and several leading companies have basically completed fast-follow catch-up. Everyone pats their chests and says that they have completed China's import substitution."

Starting in 2021, the speed of approval for domestic surgical robots to be launched will increase significantly, as far as the reporter knows. In August this year, the Ministry of Industry and Information Technology disclosed that since 2021, more than 20 domestic medical robots have been registered and certified, with products covering multiple segments such as abdominal cavity, orthopedics, neurosurgery, vascular intervention, and oral implants.

Judging from the current market, although domestic surgical robot companies are in the process of rapid incubation and growth, the industry is still in the early stages of development. Technology, research and development, and time costs are all issues that urgently need to be solved. But the good news is that , investment and financing in the domestic surgical robot industry have accelerated significantly. According to statistics, the number of investment and financing has increased significantly, and the total financing amount of the entire track exceeds 3 billion yuan. According to forecasts by Frost & Sullivan, a global business growth consulting firm, my country's surgical robot market will reach US$3.8 billion (approximately 26.5 billion yuan) by 2026, with a compound annual growth rate of 44.3%.

Editor: Yan Yuan Editor-in-Chief: Chen Yanpeng

The above is the detailed content of "Dancer on the Egg Membrane": Domestic surgical robots have been approved for launch. Who will challenge the leading position of "Da Vinci"?. For more information, please follow other related articles on the PHP Chinese website!

Statement:
This article is reproduced at:sohu.com. If there is any infringement, please contact admin@php.cn delete